These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 38062876)

  • 1. DBC1 maintains skeletal muscle integrity by enhancing myogenesis and preventing myofibre wasting.
    Liang N; He J; Yan J; Han X; Zhang X; Niu Y; Sha W; Li J
    J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):255-269. PubMed ID: 38062876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FoxP1 is a transcriptional repressor associated with cancer cachexia that induces skeletal muscle wasting and weakness.
    Neyroud D; Nosacka RL; Callaway CS; Trevino JG; Hu H; Judge SM; Judge AR
    J Cachexia Sarcopenia Muscle; 2021 Apr; 12(2):421-442. PubMed ID: 33527776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CREG1 deficiency impaired myoblast differentiation and skeletal muscle regeneration.
    Song H; Tian X; He L; Liu D; Li J; Mei Z; Zhou T; Liu C; He J; Jia X; Yang Z; Yan C; Han Y
    J Cachexia Sarcopenia Muscle; 2024 Apr; 15(2):587-602. PubMed ID: 38272853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Group I Paks support muscle regeneration and counteract cancer-associated muscle atrophy.
    Cerquone Perpetuini A; Re Cecconi AD; Chiappa M; Martinelli GB; Fuoco C; Desiderio G; Castagnoli L; Gargioli C; Piccirillo R; Cesareni G
    J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):727-746. PubMed ID: 29781585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-182 attenuates atrophy-related gene expression by targeting FoxO3 in skeletal muscle.
    Hudson MB; Rahnert JA; Zheng B; Woodworth-Hobbs ME; Franch HA; Price SR
    Am J Physiol Cell Physiol; 2014 Aug; 307(4):C314-9. PubMed ID: 24871856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia.
    Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H
    Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6 initiates muscle- and adipose tissue wasting in a novel C57BL/6 model of cancer-associated cachexia.
    Pototschnig I; Feiler U; Diwoky C; Vesely PW; Rauchenwald T; Paar M; Bakiri L; Pajed L; Hofer P; Kashofer K; Sukhbaatar N; Schoiswohl G; Weichhart T; Hoefler G; Bock C; Pichler M; Wagner EF; Zechner R; Schweiger M
    J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):93-107. PubMed ID: 36351437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscle weakness and mitochondrial stress occur before severe metastasis in a novel mouse model of ovarian cancer cachexia.
    Delfinis LJ; Ogilvie LM; Khajehzadehshoushtar S; Gandhi S; Garibotti MC; Thuhan AK; Matuszewska K; Pereira M; Jones RG; Cheng AJ; Hawke TJ; Greene NP; Murach KA; Simpson JA; Petrik J; Perry CGR
    Mol Metab; 2024 Aug; 86():101976. PubMed ID: 38925248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skeletal muscle-specific Prmt1 deletion causes muscle atrophy via deregulation of the PRMT6-FOXO3 axis.
    Choi S; Jeong HJ; Kim H; Choi D; Cho SC; Seong JK; Koo SH; Kang JS
    Autophagy; 2019 Jun; 15(6):1069-1081. PubMed ID: 30653406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. m
    Liu Y; Zhou T; Wang Q; Fu R; Zhang Z; Chen N; Li Z; Gao G; Peng S; Yang D
    J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1210-1223. PubMed ID: 35142084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Handelin alleviates cachexia- and aging-induced skeletal muscle atrophy by improving protein homeostasis and inhibiting inflammation.
    Zhang HJ; Wang BH; Wang X; Huang CP; Xu SM; Wang JL; Huang TE; Xiao WL; Tian XL; Lan XQ; Wang QQ; Xiang Y
    J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):173-188. PubMed ID: 38009816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triptolide prevents LPS-induced skeletal muscle atrophy via inhibiting NF-κB/TNF-α and regulating protein synthesis/degradation pathway.
    Fang WY; Tseng YT; Lee TY; Fu YC; Chang WH; Lo WW; Lin CL; Lo YC
    Br J Pharmacol; 2021 Aug; 178(15):2998-3016. PubMed ID: 33788266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posttranslational modifications control FoxO3 activity during denervation.
    Bertaggia E; Coletto L; Sandri M
    Am J Physiol Cell Physiol; 2012 Feb; 302(3):C587-96. PubMed ID: 22094330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-directed myostatin inhibition enhances muscle mass and function in tumor-bearing mice.
    Murphy KT; Chee A; Gleeson BG; Naim T; Swiderski K; Koopman R; Lynch GS
    Am J Physiol Regul Integr Comp Physiol; 2011 Sep; 301(3):R716-26. PubMed ID: 21677277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein therapy of skeletal muscle atrophy and mechanism by angiogenic factor AGGF1.
    He Z; Song Q; Yu Y; Liu F; Zhao J; Un W; Da X; Xu C; Yao Y; Wang QK
    J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):978-991. PubMed ID: 36696895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myricanol rescues dexamethasone-induced muscle dysfunction via a sirtuin 1-dependent mechanism.
    Shen S; Liao Q; Liu J; Pan R; Lee SM; Lin L
    J Cachexia Sarcopenia Muscle; 2019 Apr; 10(2):429-444. PubMed ID: 30793539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RBP4 promotes denervation-induced muscle atrophy through STRA6-dependent pathway.
    Zhang KZ; Li JW; Xu JS; Shen ZK; Lin YS; Zhao C; Lu X; Rui YF; Gao W
    J Cachexia Sarcopenia Muscle; 2024 Aug; 15(4):1601-1615. PubMed ID: 39031684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KLF13 restrains Dll4-muscular Notch2 axis to improve the muscle atrophy.
    Yang S; Xiong L; Yang G; Xiang J; Li L; Kang L; Liang Z
    J Cachexia Sarcopenia Muscle; 2024 Oct; 15(5):1869-1882. PubMed ID: 38973459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Foxo3 Knockdown Mediates Decline of
    Gellhaus B; Böker KO; Gsaenger M; Rodenwaldt E; Hüser MA; Schilling AF; Saul D
    Cells; 2023 Aug; 12(17):. PubMed ID: 37681900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined fibre atrophy and decreased muscle regeneration capacity driven by mitochondrial DNA alterations underlie the development of sarcopenia.
    Kimoloi S; Sen A; Guenther S; Braun T; Brügmann T; Sasse P; Wiesner RJ; Pla-Martín D; Baris OR
    J Cachexia Sarcopenia Muscle; 2022 Aug; 13(4):2132-2145. PubMed ID: 35765148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.